Alector Inc (ALEC) Stock Price, Quote & News

Company Profile

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potent...

Industry: Biotechnology

Sector: Healthcare

Phone: 415 231 5660

Website: www.alector.com

Address:

131 Oyster Point Boulevard, Suite 600, South San Francisco, United States

Few_erish Apr. 1 at 6:09 PM

$ALEC watching for reclaim

0 · Reply

notreload_ai Mar. 10 at 2:24 PM

$ALEC $CLRB $DNTH $FSS $HIMS -- THE WSJ

0 · Reply

Nothere2023 Mar. 10 at 1:47 PM

$ALEC Hold

0 · Reply

Pedrogs87 Mar. 10 at 11:50 AM

$ALEC BTIG upgrades Alector with a $6.00 price target. Previous rating adjustments showed downgrades from multiple analysts. Today, Alector (ALEC) received a significant upgrade from BTIG analyst Thomas Shrader. Shrader has moved the rating from 'Neutral' to 'Buy', setting a new price target of $6.00. This change reflects renewed confidence in Alector's market position and potential growth.

0 · Reply

Pedrogs87 Mar. 10 at 11:48 AM

$ALEC https://www.investing.com/news/analyst-ratings/alector-stock-rating-upgraded-to-buy-at-btig-on-bbbshuttle-focus-93CH-4551550

0 · Reply

Nothere2023 Mar. 9 at 3:46 PM

$ALEC Break 2.5 for 3 💪👍🚀🚀

0 · Reply

Nothere2023 Mar. 9 at 2:57 PM

$ALEC rally starts

0 · Reply

Pedrogs87 Mar. 9 at 2:56 PM

$ALEC

0 · Reply

Nothere2023 Mar. 6 at 3:20 PM

$ALEC Tbis should rocket back by next week !! No worries Excellent set up !!

0 · Reply

Fringe Mar. 5 at 8:58 PM

$ALEC how low does it drop this time?

0 · Reply

Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Feb 25, 2026, 4:05 PM EST - 5 weeks ago

Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 24, 2026, 8:00 AM EST - 5 weeks ago

Alector to Participate in the TD Cowen 46th Annual Health Care Conference

Dec 12, 2025, 4:05 PM EST - 4 months ago

Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer

Dec 8, 2025, 6:27 PM EST - 4 months ago

Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript

Dec 1, 2025, 4:05 PM EST - 4 months ago

Alector to Participate in the Bank of America CNS Therapeutics Conference

Nov 26, 2025, 11:00 AM EST - 4 months ago

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

Nov 6, 2025, 4:05 PM EST - 5 months ago

Alector Reports Third Quarter 2025 Financial Results and Provides Business Update

Oct 22, 2025, 12:07 PM EDT - 5 months ago

Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce

Oct 21, 2025, 6:45 PM EDT - 5 months ago

Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic

Oct 21, 2025, 6:41 PM EDT - 5 months ago

Alector shares plunge after dementia drug fails to slow disease progression

Oct 21, 2025, 4:05 PM EDT - 5 months ago

Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update

Oct 10, 2025, 4:32 AM EDT - 6 months ago

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals

ALDX BDTX CHRS

Sep 22, 2025, 9:03 PM EDT - 6 months ago

Alector, Inc. - Special Call

Sep 16, 2025, 8:00 AM EDT - 7 months ago

Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs

Sep 8, 2025, 4:45 PM EDT - 7 months ago

Alector, Inc. (ALEC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 28, 2025, 8:00 AM EDT - 7 months ago

Alector to Participate in Upcoming Healthcare Conferences

Aug 9, 2025, 2:35 AM EDT - 8 months ago

Alector, Inc. (ALEC) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 8 months ago

Alector Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 31, 2025, 4:05 PM EDT - 8 months ago

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

Jun 13, 2025, 4:05 PM EDT - 10 months ago

Alector Provides Executive Leadership Update

Jun 3, 2025, 8:00 AM EDT - 10 months ago

Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 8, 2025, 4:05 PM EDT - 11 months ago

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease

GSK

Feb 27, 2025, 1:09 AM EST - 1 year ago

Alector, Inc. (ALEC) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 1 year ago

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 19, 2025, 4:05 PM EST - 1 year ago

Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call

Jan 13, 2025, 8:00 AM EST - 1 year ago

Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025

Dec 4, 2024, 2:20 PM EST - 1 year ago

Neurology-Focused Alector Downgraded On Failed Alzheimer's Study, BofA Securities Highlights Lack Of Catalysts

Nov 26, 2024, 10:29 AM EST - 1 year ago

Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce

Nov 25, 2024, 4:05 PM EST - 1 year ago

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer's Disease and Provides Business Update

Nov 14, 2024, 4:05 PM EST - 1 year ago

Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

Nov 6, 2024, 4:05 PM EST - 1 year ago

Alector Reports Third Quarter 2024 Financial Results and Provides Business Update

Aug 8, 2024, 11:53 PM EDT - 1 year ago

Alector, Inc. (ALEC) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:05 PM EDT - 1 year ago

Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Alector to Host Mid-Year Earnings Conference Call

Jul 28, 2024, 8:05 AM EDT - 1 year ago

Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

Feb 27, 2024, 11:23 PM EST - 2 years ago

Alector, Inc. (ALEC) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 20, 2024, 4:05 PM EST - 2 years ago

Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call

Feb 8, 2024, 7:00 AM EST - 2 years ago

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer's Disease

Feb 7, 2024, 7:00 AM EST - 2 years ago

FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)

Jan 19, 2024, 9:20 AM EST - 2 years ago

Alector Announces Closing of Public Offering

Jan 17, 2024, 5:32 PM EST - 2 years ago

Alector: Q4 2024 Data Release Could Provide Major Shift For Valuation

Jan 17, 2024, 8:54 AM EST - 2 years ago

Alector Announces Pricing of Public Offering of Common Stock

Jan 16, 2024, 4:01 PM EST - 2 years ago

Alector Announces Proposed Public Offering of Common Stock

Few_erish Apr. 1 at 6:09 PM

$ALEC watching for reclaim

0 · Reply

notreload_ai Mar. 10 at 2:24 PM

$ALEC $CLRB $DNTH $FSS $HIMS -- THE WSJ

0 · Reply

Nothere2023 Mar. 10 at 1:47 PM

$ALEC Hold

0 · Reply

Pedrogs87 Mar. 10 at 11:50 AM

0 · Reply

Pedrogs87 Mar. 10 at 11:48 AM

$ALEC https://www.investing.com/news/analyst-ratings/alector-stock-rating-upgraded-to-buy-at-btig-on-bbbshuttle-focus-93CH-4551550

0 · Reply

Nothere2023 Mar. 9 at 3:46 PM

$ALEC Break 2.5 for 3 💪👍🚀🚀

0 · Reply

Nothere2023 Mar. 9 at 2:57 PM

$ALEC rally starts

0 · Reply

Pedrogs87 Mar. 9 at 2:56 PM

$ALEC

0 · Reply

Nothere2023 Mar. 6 at 3:20 PM

$ALEC Tbis should rocket back by next week !! No worries Excellent set up !!

0 · Reply

Fringe Mar. 5 at 8:58 PM

$ALEC how low does it drop this time?

0 · Reply

Nothere2023 Mar. 5 at 8:05 PM

$ALEC This looks like good price to get in ?

0 · Reply

Fringe Mar. 2 at 2:52 PM

$ALEC back to $2 Run is over just like that.

0 · Reply

OfficialStocktwitsUser Feb. 27 at 9:09 PM

$ALEC RSI: 74.74, MACD: 0.1490 Vol: 0.20, MA20: 2.04, MA50: 1.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

revuelto Feb. 26 at 7:27 PM

$ALEC buy the…✌️

0 · Reply

Crowbar20 Feb. 26 at 6:13 PM

$ALEC beast. This was $2.12 at open! Lets get over $2.50 and run.

0 · Reply

Pedrogs87 Feb. 25 at 10:17 PM

$ALEC https://www.stocktitan.net/sec-filings/ALEC/10-k-alector-inc-files-annual-report-2226abbd5376.html

0 · Reply

Pedrogs87 Feb. 25 at 10:16 PM

$ALEC https://www.sec.gov/ix?doc=/Archives/edgar/data/1653087/000119312526071557/alec-20260225.htm

0 · Reply

Pedrogs87 Feb. 25 at 6:42 PM

$ALEC

0 · Reply

Aawilliam2003 Feb. 11 at 2:22 PM

$PASG FTD is a tough one to solve. Raising progranulin levels apparently doesn’t work as $ALEC showed. Does anyone think this could be different for some reason?

0 · Reply

BillionerOfKing Feb. 9 at 3:24 PM

$ALEC Current Stock Price: $1.94 Contracts to trade: $2.0 ALEC Feb 20 2026 Call Entry: $0.05 Exit: $0.08 ROI: 84% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

peepthestamp Jan. 24 at 1:38 AM

$ALEC

0 · Reply

BioTechHealthX Jan. 23 at 5:16 PM

$ALEC While critics focus on declining sales forecasts, Alector, Inc. (NASDAQ: ALEC) is building something far bigger beneath the surface, targeting immune pathways in neurodegenerative diseases with asymmetric upside few biotech stocks can match. https://biotechhealthx.com/biotech-news/alector-alec-isnt-chasing-revenue-its-chasing-a-breakthrough-the-market-cant-ignore/

0 · Reply

Market Cap	265.98M
Revenue (ttm)	21.05M
Net Income (ttm)	-142.93M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-679.00%
Debt to Equity Ratio	0.32

Volume	1,316,800
Avg Vol	863,112
Day's Range	N/A - N/A
Shares Out	110.36M
Stochastic %K	67%
Beta	0.58
Analysts	Sell
Price Target	$2.88